Skip to content

Effect of Tiligidine versus Oliceridine on Postoperative Global Recovery Quality in Elderly Patients Undergoing Laparoscopic Gastrointestinal Tumor Surgery

Effect of Tiligidine versus Oliceridine on Postoperative Global Recovery Quality in Elderly Patients Undergoing Laparoscopic Gastrointestinal Tumor Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129265
Enrollment
Unknown
Registered
2026-08-03
Start date
2026-08-04
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

Tegileridine Group:Tegileridine

Sponsors

Changzhi people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 65–80 years, any gender, scheduled for laparoscopic radical resection of gastric, colon or rectal cancer; 2.ASA physical status ?–? and NYHA cardiac function classification ?–?; 3.Clear consciousness and capable of completing QoR-40 questionnaire, NRS pain assessment and follow-up visits; 4.Basically normal hepatic, renal and coagulation function; 5.Voluntarily sign informed consent and comply with the whole study and follow-up procedures; 6.Expected moderate to severe postoperative pain requiring analgesia;

Exclusion criteria

Exclusion criteria: 1.Patients with allergy to tegileridine, oliceridine or any opioids; 2.Severe respiratory dysfunction (severe chronic obstructive pulmonary disease, respiratory failure) or NYHA cardiac function class ? and above; 3.Severe hepatic and renal failure; 4.Mental disorders or cognitive impairment that hinder questionnaire assessment and follow-up; 5.Administration of opioid analgesics, glucocorticoids or immunosuppressants within one week before surgery; 6.Coagulopathy, active gastrointestinal bleeding, or intraoperative blood loss = 500 mL; 7.Confirmed or suspected gastrointestinal obstruction, including paralytic ileus;

Design outcomes

Primary

MeasureTime frame
Quality of Recovery-40 (QoR-40) score;

Secondary

MeasureTime frame
Analgesic satisfaction score;Total length of hospital stay;C-reactive protein (CRP);Neutrophil-to-lymphocyte ratio (NLR);Time to first flatus, defecation and first ambulation;PCA presses and rescue analgesia rate within 48 h postoperatively;Numeric Rating Scale (NRS) pain score;Incidence of adverse events within 48 hours postoperatively;Intraoperative mean arterial pressure (MAP) and heart rate (HR);

Countries

China

Contacts

Public ContactXiaoyan Ma

Changzhi people's Hospital

66846396@qq.com+86 132 2365 1919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026